BETHLEHEM, Pa., Feb. 13, 2024 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection, 1,000 mL (2 units/mL), the fifth product in its portfolio of Heparin premixed bags.
US FDA approves CorMedix`s drug for bloodstream infections
Enforcement Report - Week of September 6, 2023
Enforcement Report - Week of August 9, 2023
Enforcement Report - Week of May 31, 2023
Enforcement Report - Week of May 24, 2023
Health Canda Issues Recall of B. Braun Medical`s Heparin sodium in 5% Dextrose injection
Bioiberica and Vall Companys invest in the circular economy to produce heparin
Enforcement Report - Week of March 15, 2023
Enforcement Report - Week of February 22, 2023